Technical Analysis for INZY - Inozyme Pharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
23.8 | 1.10% | 0.26 |
INZY closed up 1.1 percent on Friday, October 23, 2020, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Up |
| Historical INZY trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| 20 DMA Support | Bullish | 2.45% | |
| Narrow Range Bar | Range Contraction | 2.45% | |
| Inside Day | Range Contraction | 2.45% | |
| 20 DMA Support | Bullish | 2.45% | |
| Up 3 Days in a Row | Strength | 0.98% | |
| Up 4 Days in a Row | Strength | 0.98% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 60 Minute Opening Range Breakout | 2 days ago | |
| Rose Above Previous Day's High | 2 days ago | |
| Up 3% | 2 days ago | |
| Up 2% | 2 days ago | |
| Up 1% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as in the early stages of development for calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Biology Pharmaceutical Industry Disease Pharmacy Molecular Biology Specialty Drugs Rare Genetic Diseases Recombinant Dna Yale University
Biotechnology Biopharmaceutical Life Sciences Biology Pharmaceutical Industry Disease Pharmacy Molecular Biology Specialty Drugs Rare Genetic Diseases Recombinant Dna Yale University
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.6499 |
| 52 Week Low | 16.1 |
| Average Volume | 86,629 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 24.93 |
| 20-Day Moving Average | 22.84 |
| 10-Day Moving Average | 23.04 |
| Average True Range | 2.02 |
| ADX | 16.54 |
| +DI | 18.49 |
| -DI | 14.54 |
| Chandelier Exit (Long, 3 ATRs ) | 20.35 |
| Chandelier Exit (Short, 3 ATRs ) | 25.63 |
| Upper Bollinger Band | 25.89 |
| Lower Bollinger Band | 19.79 |
| Percent B (%b) | 0.66 |
| BandWidth | 26.70 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.37 |
| MACD Histogram | 0.255 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 25.15 | ||||
| Resistance 3 (R3) | 25.23 | 24.86 | 24.93 | ||
| Resistance 2 (R2) | 24.86 | 24.52 | 24.82 | 24.85 | |
| Resistance 1 (R1) | 24.33 | 24.30 | 24.60 | 24.25 | 24.77 |
| Pivot Point | 23.96 | 23.96 | 24.09 | 23.92 | 23.96 |
| Support 1 (S1) | 23.43 | 23.62 | 23.70 | 23.35 | 22.83 |
| Support 2 (S2) | 23.06 | 23.40 | 23.02 | 22.75 | |
| Support 3 (S3) | 22.53 | 23.06 | 22.68 | ||
| Support 4 (S4) | 22.45 |
